「小細胞肺癌における抗体薬物複合体の新規治療標的の探索」の関連論文
-
抗がん分子標的抗体療法に向けての基礎研究
-
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
-
肺腺癌における転写因子ASCL1の機能解析
-
消化器神経内分泌がんの細胞株を使用した前臨床モデルとPARP阻害剤、EZH2阻害剤の有用性に関する検討
-
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer
-
Identification and Functional Analysis of Genes Critical to Tumorigenesis
-
The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia
-
Developing and optimizing chimeric antigen receptor T cell approaches for the treatment of canine cancers
-
がん幹細胞性の維持に寄与する因子の解析
-
細胞外小胞によるがん悪性化機構の解明に関する研究 (本文)
-
小児固形腫瘍に対する多層性解析による新規標的治療の創出
-
非小細胞肺癌におけるインテグリンα11の発現と術後再発に関する解析
-
Newly established patient-derived organoid model of intracranial meningioma
-
ヒト腫瘍環境内に見られる抗硫酸化グリコサミノグリカン抗体の機能解析
-
癌幹細胞関連分子BEX2を抑制する小分子化合物の同定
-
非小細胞肺癌の薬剤感受性に関する研究
-
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma
-
癌患者ゲノミクスデータ解析を基盤とした乳癌幹細胞性維持機構の解明
-
骨肉腫と免疫細胞の相互作用の解明による骨肉腫に対する新規治療標的の探索
-
淡明細胞型腎癌における線維芽細胞増殖因子受容体タイプ4の発現と機能の解析
-
A novel patient-derived pancreatic acinar cell carcinoma cell line shows high sensitivity to bortezomib
-
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
-
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
-
大腸癌における抗癌剤によるカルレティクリン誘導機序の解明
-
HER2 標的抗体薬物複合体、トラスツズマブデルクステカン(T-DXd)の免疫系への作用に関する解析
-
Susceptibility of pancreatic cancer stem cells to reprogramming
-
膵癌の薬剤抵抗性におけるKEAP1-Nrf2経路の意義に関する検討
-
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors
-
固形腫瘍に対する遺伝子改変T細胞と腫瘍溶解ウイルスによる複合免疫療法の開発
-
NK細胞のエフェクター機能制御をターゲットとした複合がん免疫薬物療法に関する研究
-
EGFR-TKI耐性と腫瘍内組織免疫微小環境との相互作用についての検討
-
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF‐β signaling
-
CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma
-
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer
-
大腸癌に対するrBC2LCNレクチン薬物複合体療法
-
Development of novel tumor antigen GPC1 specific chimeric antigen recepter transduced T(CAR-T)cell and evaluation of combination immunotherapy with anti-PD-1 Ab
-
新たな大腸癌幹細胞モデルCD44陽性COLO 201細胞の同定ならびにその性質解析
-
Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancer
-
Elucidation of the factors regulating high invasiveness of pancreatic cancer and the profound involvement of Interleukin 32 in the invasive mechanisms of the tumor cells
-
Runx3の下流遺伝子群の解析による悪性黒色腫に対する新規治療標的の創出
-
Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
-
Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity
-
皮膚T細胞リンパ腫におけるCD147, Cyclophilin Aの役割
-
CEAを標的抗原とするキメラ抗原受容体T細胞による膵臓癌への抗腫瘍効果の研究
-
Integrative analysis of cancer dependency data and comprehensive phosphoproteomics data revealed the EPHA2-PARD3 axis as a cancer vulnerability in KRAS-mutant colorectal cancer
-
Analysis of cancer-associated haptoglobin using a next generation glycan antibody
-
Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer
-
可溶性ALK1発現型HSV-1のヒト腎細胞癌における治療効果の検討
-
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours